Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention.
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina. Electronic address: tracy.wang@duke.edu.
Tracy Y
TY
Wang
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
Lisa
L
McCoy
Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, Minnesota.
Timothy D
TD
Henry
Lilly USA, LLC, Indianapolis, Indiana.
Mark B
MB
Effron
University of Colorado School of Medicine, Aurora, Colorado.
John C
JC
Messenger
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
David J
DJ
Cohen
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
Daniel B
DB
Mark
Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, New York.
Gregg W
GW
Stone
Lilly USA, LLC, Indianapolis, Indiana.
Marjorie
M
Zettler
Mayo Clinic, Rochester, Minnesota.
Mandeep
M
Singh
Ahmanson-UCLA Cardiomyopathy Center, Los Angeles, California.
Gregg C
GC
Fonarow
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
Eric D
ED
Peterson
D005500:Follow-Up Studies; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D009203:Myocardial Infarction / Q000628:therapy*; D010351:Patient Discharge; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate / Q000639:trends; D013997:Time Factors; D014481:United States / Q000453:epidemiology; D028761:Withholding Treatment
D010975:Platelet Aggregation Inhibitors